The regulatory file for zinc malate
Zinc is a nutrient in every major market; zinc malate as a form is a separate question. The file for a destination has to show which route the salt is placed on, the contaminant ceilings that apply to the finished product, the label particulars and the claim wording the market allows. The buyer's regulatory team confirms the route. This page lists the framework and the documents the file needs.
The specification describes the powder; the regulatory file has to show the route, the limits and the label for the destination.
Four checks, and why the form matters
The first check is the route. A mineral salt can be placed on the market as a food supplement ingredient, as a food additive, as a fortified-food ingredient or, where the form has no history of use, through a novel-food authorisation. Those are different legal instruments with different evidence. The second check is contaminants, the third is labelling and the fourth is claims. A lot that meets the catalog specification has cleared none of them by itself.
The route is form-specific. Permission for zinc citrate, zinc gluconate or zinc oxide is permission for that salt, not for the malate, and a supplier certificate does not create a permission. A purchase order can outrun the file here: the formula works, but the destination list names a different anion. The buyer's regulatory team confirms the route for the destination and records the basis.
Great Britain and Northern Ireland do not share one file. GB uses its own registers and labelling rules; Northern Ireland follows the EU framework.
European Union
Food supplements fall under Directive 2002/46/EC. Annex I lists the vitamins and minerals that may be used, and Annex II lists the permitted forms of each. Zinc is on Annex I; the form has to be on Annex II. The current consolidated text has to be checked for the malate entry, because an entry for another zinc salt does not carry over. If the form is not listed for supplements, the buyer's team looks at another route, such as a novel-food authorisation under Regulation (EU) 2015/2283, a food-additive use under Regulation (EC) No 1333/2008, or addition to foods under Regulation (EC) No 1925/2006.
The contaminant rules for supplements sit in Regulation (EU) 2023/915, in force since 25 May 2023 and the replacement for Regulation (EC) No 1881/2006. For the label, Regulation (EU) No 1169/2011 applies together with the supplement particulars in Directive 2002/46/EC. Claims are governed by Regulation (EC) No 1924/2006 and the authorised list in Regulation (EU) No 432/2012. The zinc reference value used for labelling is 10 mg per day; the source-of-zinc nutrition claim needs 15% of that figure in the daily portion, which is 1.5 mg of elemental zinc. Check the current text before artwork is signed.
United States
As of this review, a zinc salt is sold in the United States as a dietary ingredient under DSHEA. The seller must be able to name, and document, the basis that makes the form lawful: a GRAS conclusion, an NDI notification, or evidence of use before 15 October 1994.
21 CFR 101.36 fixes the Supplement Facts format. The panel declares how much elemental zinc a serving supplies and what percentage of the Daily Value that is; the DV for adults and children four years and older is 11 mg. The ingredient line names the salt, so “zinc malate” and “zinc citrate” cannot be swapped on a US label just because the zinc figure matches.
A structure/function statement must be truthful and substantiated, and it must carry the DSHEA disclaimer in 21 CFR 101.93. The marketer files a notification with the FDA no later than 30 days after first marketing the product. Disease claims are outside the route. Identity testing of the dietary ingredient is required by the cGMP rule in 21 CFR 111. Federal law sets no lead maximum for supplements; California's Proposition 65 does set a dose-based limit, which the brand checks.
Contaminants and the finished-product calculation
The contaminant ceiling applies to the product as sold, not to the drum. The salt's own limit has to be converted through the dose, and the conversion changes with the serving size. At a 30 mg salt serving in a 500 mg capsule the salt is 6% of the product mass; at a 150 mg serving in a 300 mg capsule it is half. The same salt result is not the same finished-product figure.
| Parameter | EU supplement ceiling at this review | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg of product | Lot result, method, limit and the dose conversion |
| Cadmium (Cd) | 1.0 mg/kg of product | Lot result and any category exception |
| Mercury (Hg) | 0.10 mg/kg of product | Lot result and method |
| Arsenic (As) | No harmonised EU supplement maximum | A buyer-set limit, stated on the specification |
For arsenic the absence of a harmonised EU figure is not a free pass: the buyer sets a limit in the specification and the certificate reports against it. The catalog line for this product is Pb ≤3 · As ≤2 · Cd ≤1 · Hg ≤0.1 mg/kg on the salt, which is a starting point for the dose calculation, not a substitute for it.
The claims boundary
In the EU, nutrition and health claims are a closed list. The source-of-zinc claim is a nutrition claim with the 15% condition above; health claims may use only the authorised wording for zinc. A claim about a deficiency, a disease or a therapeutic outcome is not permitted, and this page does not reproduce claim text for the brand to copy.
In the United States, a structure/function statement is allowed with the disclaimer and the notification, while a disease claim is not. A certificate is not a claim approval, and a claim cannot rewrite the specification. The salt name and the elemental zinc figure should be identical across the label, the specification and the COA.
The document pack
Start with the versioned specification and the lot COA. Add the technical data sheet and the SDS, then the origin record, the allergen and GMO statements, the residual-solvent statement (where a solvent is used), the element and microbiology results, and the change-control history. Halal, kosher and non-irradiation statements are added where the market requires them. A folder of undated PDFs is not a file; each document should name the product, the specification version and, where relevant, the lot.
Checklist before the first order
- The salt name, CAS 2847-05-4 and the specification version are named.
- The destination route is confirmed in writing by the buyer's regulatory team.
- The dose conversion for every contaminant result is on file.
- The label particulars and the claim wording are reviewed for the market.
- The document pack is complete and dated, and the COA matches the lot.
- Source, process and pack are under change control.
Begin with the zinc malate catalog page for the specification, then the COA page for the lot certificate and the identity page for the analytical evidence. The ICP-MS note describes the element panel, and the quality page describes the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation